Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesHepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins
Renal Failure, 11/25/09
Rydzewska–Rosoowska A et al. – There were no differences in cytokine profile comparing both their peak concentrations and the areas under the curve. Enoxaparin, dalteparin, and nadroparin are seemingly not different considering the release of HGF/Act A/FS during HD procedures; this may reflect their similar profile in other aspects. Moreover, the concentrations of HGF/Act A/FS are close to therapeutic ones, which may partly explain the mechanisms underlying some of the emerging extra–anticoagulant effects of LMWHs.
Related Articles
Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09
Relevance Score: 90%
Improved Nutrition After Conversion to Nocturnal Home Hemodialysis
Journal of Renal Nutrition, 10/14/09
Relevance Score: 89%
Permanent Hearing Loss With Iopamidol Following Aortic Angiography in a Hemodialysis Patient: A Case Report and Review of the Literature
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 87%
Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease
American Journal of Nephrology, 10/16/09
Relevance Score: 87%
Revised Dyadic Adjustment Scale as a Reliable Tool for Assessment of Quality of Marital Relationship in Patients on Long-Term Hemodialysis
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 87%
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy
Journal of Obstetrics and Gynaecology Research, 02/09/10
Reappraisal of the Impact of Race on Survival in Patients on Dialysis
American Journal of Kidney Diseases, 02/09/10
Outcomes of Commercial Renal Transplantation: A Canadian Experience
Transplantation, 02/09/10
Article Search
Sponsor